IGM Biosciences Inc (IGMS)
9.18
-0.11
(-1.18%)
USD |
NASDAQ |
May 17, 16:00
9.18
0.00 (0.00%)
After-Hours: 20:00
IGM Biosciences Free Cash Flow: -194.58M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -194.58M |
| December 31, 2023 | -204.61M |
| September 30, 2023 | -195.71M |
| June 30, 2023 | -195.63M |
| March 31, 2023 | -29.13M |
| December 31, 2022 | -16.06M |
| September 30, 2022 | -12.57M |
| June 30, 2022 | -6.097M |
| March 31, 2022 | -145.76M |
| Date | Value |
|---|---|
| December 31, 2021 | -138.23M |
| September 30, 2021 | -131.21M |
| June 30, 2021 | -116.20M |
| March 31, 2021 | -101.63M |
| December 31, 2020 | -85.38M |
| September 30, 2020 | -68.00M |
| June 30, 2020 | -62.33M |
| March 31, 2020 | -56.48M |
| December 31, 2019 | -47.45M |
Free Cash Flow Range, Past 5 Years
-204.61M
Minimum
Dec 2023
-6.097M
Maximum
Jun 2022
-100.39M
Average
-93.50M
Median
Free Cash Flow Benchmarks
| Akoya Biosciences Inc | -55.62M |
| Xilio Therapeutics Inc | -53.87M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.89M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -42.42M |
| Cash from Investing (Quarterly) | 8.651M |
| Cash from Financing (Quarterly) | 0.152M |
| Free Cash Flow Per Share (Quarterly) | -0.7469 |
| Free Cash Flow to Equity (Quarterly) | -44.90M |
| Free Cash Flow to Firm (Quarterly) | -44.90M |
| Free Cash Flow Yield | -37.56% |